CCNY
Cyclin-Y
Also known as: C10orf9, CBCP1, CCNY_HUMAN, CFP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8ND76
- Gene
- CCNY
- Ensembl
- ENSG00000108100
- Chromosome
- 10
- Canonical length
- 341 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
Cyclins, such as CCNY, control cell division cycles and regulate cyclin-dependent kinases (e.g., CDC2; MIM 116940) (Li et al., 2009 [PubMed 18060517]).[supplied by OMIM, May 2009]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>Q8ND76|CCNY
1 MGNTTSCCVS SSPKLRRNAH SRLESYRPDT DLSREDTGCN LQHISDRENI DDLNMEFNPS
61 DHPRASTIFL SKSQTDVREK RKSLFINHHP PGQIARKYSS CSTIFLDDST VSQPNLKYTI
121 KCVALAIYYH IKNRDPDGRM LLDIFDENLH PLSKSEVPPD YDKHNPEQKQ IYRFVRTLFS
181 AAQLTAECAI VTLVYLERLL TYAEIDICPA NWKRIVLGAI LLASKVWDDQ AVWNVDYCQI
241 LKDITVEDMN ELERQFLELL QFNINVPSSV YAKYYFDLRS LAEANNLSFP LEPLSRERAH
301 KLEAISRLCE DKYKDLRRSA RKRSASADNL TLPRWSPAII SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCNY can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- testis: 74 nTPM
- cerebral cortex: 38 nTPM
- amygdala: 37 nTPM
- placenta: 36 nTPM
- basal ganglia: 35 nTPM
- bone marrow: 34 nTPM
Single-cell type
- late spermatids: 6,772 nCPM
- early spermatids: 1,191 nCPM
- oligodendrocytes: 515 nCPM
- neutrophils: 485 nCPM
- vascular endothelial cells: 403 nCPM
- microglia: 386 nCPM
Immune cell
- neutrophil: 26 nTPM
- classical monocyte: 23 nTPM
- myeloid DC: 7.8 nTPM
- total PBMC: 7.6 nTPM
- intermediate monocyte: 6.5 nTPM
- eosinophil: 5.2 nTPM
Brain region
- hippocampal formation: 56 nTPM
- cerebral cortex: 56 nTPM
- basal ganglia: 55 nTPM
- thalamus: 54 nTPM
- amygdala: 52 nTPM
- midbrain: 49 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.81
- gnomAD missense Z
- 2.04
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- G2/M transition of mitotic cell cycle
- positive regulation of autophagy
- positive regulation of cyclin-dependent protein serine/threonine kinase activity
- regulation of canonical Wnt signaling pathway
- spermatogenesis
- Wnt signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCNY in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCNY as an antibody target. Whether an autoantibody or antibody against CCNY could matter depends on whether native CCNY is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCNY is annotated at the cell surface, where native CCNY is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CCNY as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...